A major breakthrough in cancer investigation is emerging with the use of VHH fragments to reactivate damaged p53. This crucial malignant suppressor protein is frequently lost in several forms of tumors, causing https://minibookmarking.com/story22079531/mini-antibodies-reactivate-tumor-suppressor-p53-the-promising-hope-for-tumor-treatment